Acampora et al., 1989 - Google Patents
Intraoperative administration of the intravenous angiotensin-converting enzyme inhibitor, enalaprilat, in a patient with congestive heart failureAcampora et al., 1989
- Document ID
- 8048162767833984339
- Author
- Acampora G
- Melendez J
- Keefe D
- Turnbull A
- Bedford R
- Publication year
- Publication venue
- Anesthesia & Analgesia
External Links
Snippet
Patients with heart failure due to coronary artery disease can be managed by afterload reduction as long as myocardial oxygen consumption is not increased by tachycardia and coronary artery perfusion pressure is not compromised. Recently, angiotensinconverting …
- 108010066671 Enalaprilat 0 title abstract description 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
- A61N1/3702—Monitoring; Protecting a physiological parameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/362—Heart stimulators
- A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardionmyopathy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0402—Electrocardiography, i.e. ECG
- A61B5/0452—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7285—Specific aspects of physiological measurement analysis for synchronising or triggering a physiological measurement or image acquisition with a physiological event or waveform, e.g. an ECG signal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/10—Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps
- A61M1/1037—Pumps having flexible elements, e.g. with membranes, diaphragms, or bladder pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kantrowitz et al. | Initial clinical experience with intraaortic balloon pumping in cardiogenic shock | |
Devereux et al. | Mitral valve prolapse. | |
Chugh et al. | First evidence of premature ventricular complex‐induced cardiomyopathy: a potentially reversible cause of heart failure | |
Seggewiss et al. | Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction | |
HEUSER et al. | Coronary angioplasty for acute mitral regurgitation due to myocardial infarction: a nonsurgical treatment preserving mitral valve integrity | |
Bregman et al. | Anomalous origin of the right coronary artery from the pulmonary artery | |
Heydorn et al. | Congenital aneurysm of the sinus of Valsalva protruding into the left ventricle: Review of diagnosis and treatment of the unruptured aneurysm | |
Rokas et al. | Electrophysiologic abnormalities of cardiac function in progressive systemic sclerosis | |
Acampora et al. | Intraoperative administration of the intravenous angiotensin-converting enzyme inhibitor, enalaprilat, in a patient with congestive heart failure | |
van Brussel et al. | Myocardial bridging: a cause of myocardial infarction? | |
Resnekov | Cardiogenic shock | |
Málek et al. | Hemodynamic Effects of the Cardioselective β‐Blocking Agent Metoprolol in Acute Myocardial Infarction: A 24‐Hour Catheterization Study | |
Nathan et al. | Fatal ventricular tachycardia in association with propafenone, a new class IC antiarrhythmic agent | |
Goetz et al. | Unidirectional intraaortic balloon pumping in cardiogenic shock and intractable left ventricular failure | |
Kocheril et al. | Radiofrequency ablation of an accessory pathway in a patient with corrected Ebstein's anomaly | |
IWAMA et al. | Hypertrophic cardiomyopathy complicated with acute myocardial infarction due to coronary embolism | |
Lindell et al. | Haemodynamic changes in chronic constrictive pericarditis during exercise and histamine infusion | |
Luani et al. | Confusion in a patient with premature ventricular complexes originating in the left ventricular summit | |
Yasuda et al. | Hyposecretion of trial natriuretic peptide due to associated right atrial infarction in a patient with acute right ventricular infarction? | |
Poelaert et al. | Transoesophageal echocardiographic evaluation of ventricular function during transvenous defibrillator implantation | |
RU2168333C2 (en) | Method for treating cardiac insufficiency | |
Ronan Jr et al. | Echocardiographic and Hemodynamic Changes During Percutaneous Cardiopulmonary Bypass Support | |
Selzer | Fifty years of progress in cardiology: a personal perspective. | |
Kumbasar et al. | Effect of intraaortic balloon counter-pulsation on QT dispersion in acute anterior myocardial infarction | |
Kothari et al. | Familial complete heart block in hypertrophic cardiomyopathy |